Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) announced on October 20, 2026, that its wholly owned subsidiary, Rocket Doctor Inc., has been selected as a finalist in the 8th Annual Digital Health & AI Awards at HLTH 2026 in Las Vegas. The company was chosen as one of only five finalists in the "Best in Class" track for the "Civic Health: Affordability, Access & Health Equity" category, drawn from a field of over 1,800 global submissions. The recognition and associated platform presentation could raise Rocket Doctor AI's profile among international healthcare investors and partners.

Key Points

  • Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) is a Vancouver-based digital health and AI company
  • Wholly owned subsidiary Rocket Doctor Inc. named a Best in Class Finalist in the "Civic Health: Affordability, Access & Health Equity" category at the 8th Annual Digital Health & AI Awards
  • Selected from over 1,800 global applicants; awards grand finale scheduled for November 16, 2026, at HLTH in Las Vegas
  • Investors may be watching the company's pitch at the "Innovations from Canada" Global Village and its performance in the awards finale

Rocket Doctor Selected From 1,800 Global Applicants for Health Equity Recognition

Rocket Doctor Inc. secured one of only five finalist positions in the Best in Class track for "Civic Health: Affordability, Access & Health Equity" at the Digital Health Hub Foundation's annual awards programme. The release states that the recognition honours companies demonstrating meaningful innovation, measurable clinical impact, and transformation across the digital health and AI ecosystem. Being shortlisted from over 1,800 worldwide submissions positions the company alongside leading global digital health innovators ahead of the November 16 grand finale in Las Vegas.

Rocket Doctor to Pitch at "Innovations from Canada" Pavilion at HLTH 2026

Beyond the award finalist designation, Rocket Doctor will participate in the "Innovations from Canada" Global Village at HLTH on November 16, 2026, delivering a pitch in the showcase. The company will also be prominently featured in the "Innovations from Canada" Pavilion, which highlights top Canadian digital health companies supported by the MaRS and D3 Accelerators. The announcement describes this dual presence — as both an award finalist and a featured exhibitor — as an opportunity to present the company's vision to healthcare leaders, investors, and health systems gathered at the event.

AI-Powered Platform and Physician Marketplace Underpin Finalist Recognition

Rocket Doctor AI's technology centres on an AI-powered digital health platform and physician marketplace, alongside its Global Library of Medicine, described in the release as a clinically validated decision support system developed with input from hundreds of physicians globally. The disclosure states the platform has supported over 350 MDs in delivering more than 800,000 patient visits. The company's stated focus on remote, rural, and underserved populations in Canada, and on Medicaid and Medicare patients in the United States, aligns directly with the health equity category in which it was recognised.